DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Niravam (Alprazolam) - Published Studies

 
 



Niravam Related Published Studies

Well-designed clinical trials related to Niravam (Alprazolam)

Comparison of alprazolam versus captopril in high blood pressure: a randomized controlled trial. [2011.08]

Efficacy of alprazolam sublingual tablets in the treatment of the acute phase of panic disorders. [2011.03]

The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder. [2011]

The effects of alprazolam on tinnitus: a cross-over randomized clinical trial. [2009.11]

Does oral alprazolam affect ventilation? A randomised, double-blind, placebo-controlled trial. [2009.05]

Absence of food effect on the extent of alprazolam absorption from an orally disintegrating tablet. [2007.08]

Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg. [2007.05]

Current approaches to the pharmacologic treatment of anxiety disorders. [2007]

Different acute tolerance development to EEG, psychomotor performance and subjective assessment effects after two intermittent oral doses of alprazolam in healthy volunteers. [2007]

Combining alprazolam with systematic desensitization therapy for dental injection phobia. [2007]

Attenuation of the hypothalamic-pituitary-adrenal axis responsivity to the Trier Social Stress Test by the benzodiazepine alprazolam. [2006.11]

The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle. [2006.10.01]

Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs. [2006.10]

Pharmacokinetics of an extended release formulation of alprazolam (Xanax XR) in healthy normal adolescent and adult volunteers. [2006.09]

A statistical approach for classifying change in cognitive function in individuals following pharmacologic challenge: an example with alprazolam. [2006.05]

[The cognitive effect of alprazolam in healthy volunteers] [2006]

A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers. [2005.12]

Sex-related elevation in cortisol during chronic treatment with alprazolam associated with enhanced cognitive performance. [2005.11]

A neurophysiological study of the detrimental effects of alprazolam on human action monitoring. [2005.10]

Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. [2005.09]

Alprazolam significantly improves the efficacy of granisetron in the prophylaxis of emesis secondary to moderately emetogenic chemotherapy in patients with breast cancer. [2005.08]

Effects of dehydroepiandrosterone and alprazolam on hypothalamic-pituitary responses to exercise. [2005.08]

A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam. [2005.06]

Sertraline and alprazolam in the treatment of panic desorder. [2005.05]

Kinetics and dynamics of intravenous adinazolam, N-desmethyl adinazolam, and alprazolam in healthy volunteers. [2005.05]

No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract. [2005.04]

A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo. [2005.02.01]

Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers. [2005]

In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam. [2004.10]

The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans. [2004.10]

Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity. [2004.06]

Lack of pharmacologic interaction between paroxetine and alprazolam at steady state in healthy volunteers. [2004.06]

Interdose elevation in plasma cortisol during chronic treatment with alprazolam but not lorazepam in the elderly. [2004.03]

Influence of hydroxypropyl methylcellulose polymer on in vitro and in vivo performance of controlled release tablets containing alprazolam. [2003.11]

Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine. [2003.08]

Well-designed clinical trials possibly related to Niravam (Alprazolam)

Effects of anxiolytic treatment on potentiated startle during aversive image anticipation. [2012]

Characterization of the cerebral activity by time-frequency representation of evoked EEG potentials. [2011.08]

Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial. [2011.06.21]

Effect of an oral anxiolytic medication and heart rate variability on image quality of 64-slice MDCT coronary angiography. [2011.02]

The acute and late CNS glutamine response to benzodiazepine challenge: a pilot pharmacokinetic study using proton magnetic resonance spectroscopy. [2010.12.30]

Ketorolac-mepivacaine lower uterine block for in-office endometrial ablation: a randomized, controlled trial. [2010.11]

Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation. [2010.08]

Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder. [2010]

[Clinical observation on therapeutic effect of the pressing plantar reflex area with wooden needle for treatment of patients with insomnia] [2009.11]

Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model. [2009.11]

Benzodiazepines for delirium. [2009.10.07]

Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. [2009.07.24]

A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety. [2009.03]

Benzodiazepines for delirium. [2009.01.21]

[Observation on the therapeutic effect of neck clustered needling on insomnia] [2008.12]

Clinical observation on post-stroke anxiety neurosis treated by acupuncture. [2008.09]

[Effect of acupuncture combined with massage of sole on sleeping quality of the patient with insomnia] [2008.06]

Relative influences of adjunctive topiramate and adjunctive lamotrigine on scanning and the effective field of view. [2008.02]

Review: Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. [2007.09]

Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder. [2007.02]

Selegiline Transdermal System: An Examination of the Potential for CYP450-Dependent Pharmacokinetic Interactions With 3 Psychotropic Medications. [2007.02]

Clinical and electromyographic characteristics of tremor in patients with generalized anxiety disorder. [2007.01]

Connectivity analysis of EEG under drug therapy. [2007]

Ultra-fast absorption of amorphous pure drug aerosols via deep lung inhalation. [2006.11]

Modeling drug detection and diagnosis with the 'drug evaluation and classification program'. [2005.09]

Drug identification performance on the basis of observable signs and symptoms. [2005.09]

Effects of group experiential cognitive therapy for the treatment of panic disorder with agoraphobia. [2005.08]

Breast core-needle biopsy: clinical trial of relaxation technique versus medication versus no intervention for anxiety reduction. [2005.01]

[Evaluation of the usefulness and effectiveness of anxiolytic therapies in neoplastic diseases] [2004.06]

Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers. [2004.02]

A 15-year follow-up study of patients with panic disorder. [2003.12]

Other research related to Niravam (Alprazolam)

Alprazolam for depression. [2012]

Cross-conditional entropy and coherence analysis of pharmaco-EEG changes induced by alprazolam. [2011.11.30]

The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder. [2011.10]

Ingestions of hydrocodone, carisoprodol, and alprazolam in combination reported to Texas poison centers. [2011.04]

High doses alprazolam induced amenorrhoea and galactorrhoea. [2011.03]

Effects of alprazolam on capture stress-related serum cortisol responses in Korean raccoon dogs (Nyctereutes procyonoides koreensis). [2011.03]

Effects of Alprazolam, Zolpidem and Zopiclone, and of chronic inflammation on peripheral experimental algesia in Wistar rats. [2011]

Inhibitory effects of alprazolam on the development of acute experimental autoimmune encephalomyelitis in stressed rats. [2010.12]

Alprazolam as an in vivo probe for studying induction of CYP3A in cynomolgus monkeys. [2010.10]

Metabolite formation kinetics and intrinsic clearance of phenacetin, tolbutamide, alprazolam, and midazolam in adenoviral cytochrome P450-transfected HepG2 cells and comparison with hepatocytes and in vivo. [2010.09]

Effects of antecedent GABAA activation with alprazolam on counterregulatory responses to hypoglycemia in healthy humans. [2010.04]

Pre-medication and renal pre-conditioning: a role for alprazolam, atropine, morphine and promethazine. [2010.04]

GABAergic modulation of human social interaction in a prisoner's dilemma model by acute administration of alprazolam. [2009.10]

Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine. [2009.07]

Effect of smoking and CYP2D6 polymorphisms on the extent of fluvoxamine-alprazolam interaction in patients with psychosomatic disease. [2009.07]

Alprazolam treatment immediately after stress exposure interferes with the normal HPA-stress response and increases vulnerability to subsequent stress in an animal model of PTSD. [2009.04]

Alprazolam intercalates into DNA. [2009.02]

Alprazolam and oxazepam block the cue-induced reinstatement of extinguished cocaine seeking in rats. [2009.01]

Does oral alprazolam affect ventilation? A randomised, double-blind, placebo-controlled trial. [2008.06.18]

Protective effect of alprazolam against sleep deprivation-induced behavior alterations and oxidative damage in mice. [2008.04]

An evaluation of data for 10 children born to mothers who attempted suicide by taking large doses of alprazolam during pregnancy. [2008.02]

Cognitive style, alprazolam plasma levels, and treatment response in panic disorder. [2008]

[Alprazolam use improves psychological status and reduces hospitalization costs in patients with paroxysmal supraventricular tachycardia underwent radiofrequency catheter ablation] [2007.10]

Anxiolytic therapy with alprazolam increases muscle sympathetic activity in patients with panic disorders. [2007.07.31]

Alprazolam induced conformational change in hemoglobin. [2007.06.01]

Protective effect of alprazolam in acute immobilization stress-induced certain behavioral and biochemical alterations in mice. [2007.05]

Sublingual use of olanzapine in combination with alprazolam to treat agitation in a terminally ill patient receiving parenteral nutrition. [2007.05]

Raman mapping of low-content API pharmaceutical formulations. I. Mapping of Alprazolam in Alprazolam/Xanax tablets. [2007.01]

Confirmation of gestational exposure to alprazolam by analysis of biological matrices in a newborn with neonatal sepsis. [2007]

Other possibly related research studies

Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model. [2008.07.17]

Complete atrioventricular block associated with concomitant use of metoprolol and paroxetine. [2008.05]

Evidenced-based pharmacologic treatment of borderline personality disorder: A shift from SSRIs to anticonvulsants and atypical antipsychotics? [2008.02.25]

Efficacy of tropisetron in patients with advanced non-small-cell lung cancer receiving adjuvant chemotherapy with carboplatin and taxanes. [2008.03]

Effect of Jin-3-needling therapy on plasma corticosteroid, adrenocorticotrophic hormone and platelet 5-HT levels in patients with generalized anxiety disorder. [2007.12]

Opioid receptors are involved in the sedative and antinociceptive effects of hesperidin as well as in its potentiation with benzodiazepines. [2008.02.12]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012